Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS
· Delayed Price · Currency is USD
1.850
+0.200 (12.12%)
At close: Dec 5, 2025
HRGN Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 0.74 | 0.43 | 0.1 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | 216.17% | 317.48% | - | - | - | - | Upgrade
|
| Cost of Revenue | 0.62 | 0.27 | 0.02 | - | - | - | Upgrade
|
| Gross Profit | 0.12 | 0.16 | 0.08 | - | - | - | Upgrade
|
| Selling, General & Admin | 4.53 | 5.14 | 6.08 | 4.4 | 7.12 | 3.33 | Upgrade
|
| Research & Development | 2.17 | 2.24 | 2.99 | 1.67 | 1.52 | 1.99 | Upgrade
|
| Operating Expenses | 6.7 | 7.39 | 9.07 | 6.07 | 8.64 | 5.33 | Upgrade
|
| Operating Income | -6.58 | -7.23 | -8.99 | -6.07 | -8.64 | -5.33 | Upgrade
|
| Interest Expense | -0.01 | -0.04 | -0.01 | -0.01 | - | - | Upgrade
|
| Interest & Investment Income | 0.05 | 0.03 | 0.06 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | - | -0.01 | 0 | 0.25 | 0.46 | Upgrade
|
| EBT Excluding Unusual Items | -6.53 | -7.23 | -8.95 | -6.07 | -8.39 | -4.87 | Upgrade
|
| Other Unusual Items | - | -0.5 | - | - | 0.41 | - | Upgrade
|
| Pretax Income | -6.53 | -7.73 | -8.95 | -6.07 | -7.98 | -4.87 | Upgrade
|
| Net Income | -6.53 | -7.73 | -8.95 | -6.07 | -7.98 | -4.87 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | 0.08 | 0.18 | - | - | Upgrade
|
| Net Income to Common | -6.53 | -7.73 | -9.02 | -6.25 | -7.98 | -4.87 | Upgrade
|
| Shares Outstanding (Basic) | 16 | 15 | 13 | 11 | 10 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 15 | 13 | 11 | 10 | 9 | Upgrade
|
| Shares Change (YoY) | 13.38% | 9.91% | 18.56% | 12.79% | 14.43% | 27.48% | Upgrade
|
| EPS (Basic) | -0.40 | -0.52 | -0.67 | -0.55 | -0.79 | -0.55 | Upgrade
|
| EPS (Diluted) | -0.40 | -0.52 | -0.67 | -0.55 | -0.79 | -0.55 | Upgrade
|
| Free Cash Flow | -4.29 | -4.85 | -6.95 | -5.11 | -2.63 | -4.05 | Upgrade
|
| Free Cash Flow Per Share | -0.27 | -0.33 | -0.52 | -0.45 | -0.26 | -0.46 | Upgrade
|
| Gross Margin | 16.29% | 37.21% | 76.70% | - | - | - | Upgrade
|
| Operating Margin | -885.87% | -1680.46% | -8728.15% | - | - | - | Upgrade
|
| Profit Margin | -878.33% | -1798.14% | -8759.22% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -577.25% | -1128.37% | -6747.57% | - | - | - | Upgrade
|
| EBITDA | -6.58 | -7.21 | -8.96 | -6.01 | -8.53 | -5.14 | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.04 | 0.05 | 0.11 | 0.18 | Upgrade
|
| EBIT | -6.58 | -7.23 | -8.99 | -6.07 | -8.64 | -5.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.